Those classical 1,4-dihydropyridines are known to act as inhibitors of the transmembrane efflux pump ABCB1 in cancer cells where they enhance the toxicity of applicated cytostatic agents [8,9,10]. This evidence concerns the gene ABCB1 and cancer.